Research, Safety & Administration

Peptides are powerful signaling molecules. Key risks to consider in research:

• GHK-Cu / AHK-Cu: May cause zinc depletion over long-term use.
• Insuliin / MOTS-c: Requires careful blood glucose monitoring due to hypoglycemia risks.
• Semax / Selank: May temporarily increase hair shedding in susceptible individuals.

Peptide bioavailability is entirely dependent on the route of administration:

• Subkutaanne: Highest bioavailability. Standard for BPC-157, TB-500, Epithalon.
• Intranasaalne: Best for crossing the blood-brain barrier (Semax, Selank, Insulin).
• Suukaudne: Requires acid-stable molecules (Argino-BPC) or specific protective transporters (Pinealon).

We transparently categorize all peptides into four tiers of evidence:

• In-Vitro: Laboratory studies on isolated cells.
• Loomkatsed: Studies conducted in rodent or mammalian models.
• Kliinilised Uuringud: Formal human trials (often Russian/Eastern European clinical use, e.g., Cerebrolysin).
• N=1 Eksperimendid: Anecdotal data from the global biohacking community.